is tirzepatide a glp-1 agonist Management of type 2 diabetes with the dual GIP/GLP-1 receptor tirzepatide: systematic review and meta-analysis | Diabetologia Semaglutide vs Tirzepatide explained simply

L-Carnitine may interact with certain medications

Start Your Program Today Wellness Support Designed Around You Health targets are individual, and the right health care should be individual

Adverse Reactions Occurring at an Incidence of 5% or More and At Least Twice Placebo Among VYVANSE Treated Patients with BED in Clinical Trials The most common adverse reactions (incidence 5% and at a rate at least twice placebo) reported in adults were dry mouth, insomnia, decreased appetite, increased heart rate, constipation, feeling jittery, and anxiety

GLP-1 agonists can improve both mental and physical health, potentially enhancing treatment engagement

Key Takeaways Prediabetes is a common, often symptomless condition driven by insulin resistance that can progress to type 2 diabetes without timely intervention